NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
ID: 359653Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $400K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359653

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-26-010.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25), aimed at enhancing training for a skilled workforce in Alzheimer's Disease (AD) and Alzheimer's Disease and Related Dementias (ADRD). This program seeks to support educational activities that provide intensive research experiences for recent baccalaureates, particularly those from underrepresented backgrounds, to prepare them for advanced degree programs or research careers in AD/ADRD. The NIH plans to commit $2,000,000 in FY 2027 and FY 2028 to fund up to five new awards annually, with a maximum project period of five years and direct costs of up to $400,000 per year. Interested applicants can find more information and application details at the provided link and should direct inquiries to grantsinfo@nih.gov, with applications due by May 26, 2027.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-AG-26-010-Full-Announcement.html
    RFA-AG-26-010.html
    The Department of Health and Human Services, National Institutes of Health (NIH), and National Institute on Aging (NIA) are reissuing a funding opportunity (RFA-AG-26-010) for the NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25). This program aims to support educational activities that enhance training opportunities for a skilled biomedical, behavioral, and clinical research workforce, specifically focusing on Alzheimer's Disease (AD) and Alzheimer's Disease and Related Dementias (ADRD). The goal is to prepare recent baccalaureates for advanced degree programs or research careers in AD/ADRD. The program emphasizes intensive research experiences, mentorship, and professional development, explicitly prohibiting participants from leading independent clinical trials. Key dates include an open date of April 27, 2026, and an expiration date of May 27, 2027. NIA intends to commit $2,000,000 in FY 2027 and FY 2028 to fund up to five new awards each year, with a maximum project period of five years and direct costs up to $400,000 annually. Eligible applicants include various higher education and non-profit institutions, with a focus on U.S. citizens and permanent residents. The application requires detailed plans for the research education program, faculty, participants, institutional environment, reproducibility, responsible conduct of research, evaluation, and dissemination.
    Similar Opportunities
    NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the NIA Expanding Research in Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) Summer Research Education Program (R25). This program aims to support the development and implementation of summer research education experiences for high school students, undergraduates, and science teachers, particularly those from underrepresented backgrounds, to enhance the research workforce in the AD/ADRD field. The initiative is crucial for providing early exposure to AD/ADRD research and encouraging participants to pursue careers in biomedical and behavioral sciences. Up to five awards of $200,000 in direct costs per year for up to five years are anticipated, with applications due by May 26, 2027. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)" aimed at developing a diverse and interdisciplinary workforce for translational research in this critical health area. The initiative invites eligible institutions to create training programs for predoctoral and postdoctoral researchers, focusing on enhancing skills in data science, disease biology, and drug discovery, while not permitting independent clinical trials. With an anticipated budget of approximately $2.7 million annually for 3-5 awards over fiscal years 2025-2027, applications are due by September 25, 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)." This initiative aims to develop a diverse, interdisciplinary workforce capable of conducting translational research on AD and ADRD, supporting training programs for predoctoral and postdoctoral researchers with varied educational backgrounds. The program emphasizes the importance of interdisciplinary collaboration and aims to enhance understanding and treatment of aging-related health issues. NIH plans to award an estimated 3-5 grants annually over the next three years, with a total budget of $2.7 million, and applications are due by September 25, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIA Postdoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Postdoctoral Fellowship Award (F32) to enhance diversity in the translational research workforce focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). This fellowship aims to support postdoctoral researchers from underrepresented backgrounds, emphasizing the development of translational research skills applicable to various aspects of AD/ADRD research, while prohibiting candidates from leading independent clinical trials. The program will fund approximately four awards totaling $420,000 in direct costs for fiscal years 2026-2028, with application cycles opening on March 8, 2025, and deadlines on April 8, August 8, and December 8 through 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-332.html.
    AD/ADRD Clinical Trials Short Course
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the AD/ADRD Clinical Trials Short Course aimed at enhancing the workforce skilled in Alzheimer's disease (AD) and AD-related dementias (ADRD) clinical trials. This initiative seeks to develop innovative short courses that will train the next generation of clinical trialists in advanced research skills pertinent to AD, frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), and mixed dementia, as well as interventions for treatment and prevention. While applications are not currently being solicited, potential applicants are encouraged to begin forming collaborations and project ideas in anticipation of the funding opportunity, which will utilize the R25 activity code. For further inquiries, interested parties can contact Laurie Ryan at the National Institute on Aging via email at ryanl@mail.nih.gov or by phone at 301-496-9350. The estimated synopsis post date is September 1, 2025, with a closing date for applications expected by January 25, 2026, and an anticipated award date of December 1, 2026.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program supports innovative projects that enhance understanding, diagnosis, treatment, and care strategies for AD/ADRD, while also promoting workforce diversity and addressing health disparities in this field. Grants of up to $100,000 for a duration of two years are available, with a total of 12 awards expected for fiscal year 2024, amounting to $1.8 million in funding. Interested applicants must be affiliated with eligible organizations and are encouraged to submit their applications by March 16, 2026, with inquiries directed to grantsinfo@nih.gov for further information.
    NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F31 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Predoctoral Fellowship Award aimed at promoting diversity in the translational research workforce focused on Alzheimer's disease and related dementias (AD/ADRD). This grant supports promising predoctoral candidates from diverse backgrounds in acquiring essential translational research skills, with an emphasis on interdisciplinary approaches to AD/ADRD research, although independent clinical trials are not permitted. The initiative is crucial for fostering a diverse pool of trained scientists capable of addressing the biomedical and social challenges associated with aging and dementia. The total funding available is $335,000 for six anticipated awards, with key application deadlines starting on March 8, 2025, and the final close date set for December 8, 2027. For more information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-333.html.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the "Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)." This program aims to support innovative research projects focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD), specifically targeting early-stage and diverse researchers who have not previously received significant NIH funding in this field. The initiative is designed to generate pilot data that can lead to larger funding applications, thereby enhancing research capabilities and workforce diversity in biomedical research. Grants of up to $100,000 per year for two years are available, with the application process opening on January 16, 2025, and the closing date set for March 16, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Diversity in Aging Research (ADAR) through Undergraduate Education," aimed at enhancing diversity in aging-related research fields. This initiative invites applications for research education programs that provide undergraduate students from underrepresented backgrounds with structured research experiences in aging, with the goal of preparing them for advanced degrees or careers in this discipline. The program emphasizes the importance of recruiting participants from diverse settings and requires a detailed recruitment plan, collaboration with existing NIH-funded programs, and comprehensive evaluation strategies. The funding limit is set at $375,000 per year, with a maximum project period of five years, and applications are due by May 25, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Advanced Postdoctoral Career Transition Awards to promote diversity in translational research related to Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity aims to support early-career investigators from underrepresented backgrounds, providing them with the necessary training and mentorship to develop critical research skills and transition into independent research roles. The program consists of two phases: the K99 phase for mentored training lasting up to two years, followed by the R00 phase, which offers independent research support for up to three years. Eligible applicants include various institutions and organizations, with a focus on enhancing the diversity of the research workforce. Interested parties should note that the application deadline is July 12, 2027, and can find more information at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.